This study aimed to find differences in the gene expression between the mucosa of IBD patients receiving 5-aminosalicylic acid (5ASA) or biological therapies in the form of anti-TNF treatment and IBD patients receiving no medication or control subjects without IBD. This evidence concerns the gene TNF and inflammatory bowel disease.